A multicenter, randomized, double-blind, double-dummy, placebo-controlled, 3-way crossover, single dose study, comparing the efficacy and safety of the Fluticasone/Salmeterol combination administered with Elpenhaler db (Rolenium) versus the innovative one (Seretide Diskus) in patients with asthma.

Next Previous
Trial Profile

A multicenter, randomized, double-blind, double-dummy, placebo-controlled, 3-way crossover, single dose study, comparing the efficacy and safety of the Fluticasone/Salmeterol combination administered with Elpenhaler db (Rolenium) versus the innovative one (Seretide Diskus) in patients with asthma.

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Therapeutic Use

    • Most Recent Events

    • 07 Jul 2011 This study has been completed in Hungary and discontinued in Greece.
    • 07 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top